Inhibitors of Rho kinase have been developed based on two distinct scaffolds, benzimidazoles, and benzoxazoles. SAR studies and efforts to optimize the initial lead compounds are described. Novel selective inhibitors of ROCK-II with excellent potency in both enzyme and cell-based assays were obtained. These inhibitors possess good microsomal stability, low cytochrome P-450 inhibitions and good oral bioavailability.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2008.10.095 | DOI Listing |
Publication Analysis
Top Keywords
inhibitors rho
8
rho kinase
8
benzimidazole- benzoxazole-based
4
inhibitors
4
benzoxazole-based inhibitors
4
kinase inhibitors
4
kinase developed
4
developed based
4
based distinct
4
distinct scaffolds
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!